Luca Scavo is the founder of Evelo Biosciences. Evelo Biosciences has raised $79M in total funding. Latest round: Growth. Backed by Flagship Pioneering.
Luca Scavo is the Chief Financial Officer at Evelo Biosciences, a clinical-stage biotechnology company. Evelo Biosciences focuses on developing orally delivered medicines that target the small intestinal axis (SINTAX) for systemic therapeutic effects. The company is developing product candidates for inflammatory diseases and cancer.
Full founder directory · Investor directory · Company funding database · Fundraising library